Brokerages Set Health Catalyst, Inc. (NASDAQ:HCAT) Price Target at $8.00

Key Points

• Health Catalyst, Inc. (NASDAQ:HCAT) has received a consensus rating of "Moderate Buy" from twelve analysts, with an average twelve-month price target of $8.00.
• Recent price objectives have been lowered by several analysts, with KeyCorp adjusting its target from $7.00 to $5.00 and Evercore ISI lowering theirs from $5.00 to $4.00.
• The company's shares are currently trading at approximately $3.52, down 3.6%, with institutional investors holding 85.00% of the company's stock.

Shares of Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) have been given an average rating of "Moderate Buy" by the twelve ratings firms that are covering the company, MarketBeat reports. Five investment analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $8.00.

Several research firms have commented on HCAT. Stifel Nicolaus lifted their price target on Health Catalyst from $5.00 to $5.50 and gave the stock a "hold" rating in a research report on Thursday, May 8th. Citigroup dropped their price objective on shares of Health Catalyst from $7.00 to $6.50 and set a "buy" rating on the stock in a research note on Friday, April 25th. KeyCorp dropped their price target on Health Catalyst from $7.00 to $5.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 16th. Canaccord Genuity Group decreased their price objective on Health Catalyst from $10.00 to $9.00 and set a "buy" rating for the company in a research report on Thursday, May 8th. Finally, BTIG Research cut Health Catalyst from a "buy" rating to a "neutral" rating in a research note on Tuesday, June 17th.

Health Catalyst Stock Performance

HCAT traded up $0.22 on Friday, reaching $3.85. The company had a trading volume of 250,880 shares, compared to its average volume of 668,085. The stock has a 50-day moving average price of $3.86 and a 200-day moving average price of $4.31. The stock has a market capitalization of $267.61 million, a PE ratio of -3.34 and a beta of 1.46. Health Catalyst has a 1 year low of $3.48 and a 1 year high of $9.24. The company has a quick ratio of 1.24, a current ratio of 1.24 and a debt-to-equity ratio of 0.40.

Hedge Funds Weigh In On Health Catalyst

Several institutional investors have recently bought and sold shares of the stock. American Century Companies Inc. lifted its position in shares of Health Catalyst by 1.8% in the 4th quarter. American Century Companies Inc. now owns 710,481 shares of the company's stock worth $5,023,000 after acquiring an additional 12,682 shares during the period. OneAscent Financial Services LLC acquired a new position in Health Catalyst in the fourth quarter worth $97,000. ExodusPoint Capital Management LP bought a new position in shares of Health Catalyst in the fourth quarter worth about $107,000. Wells Fargo & Company MN lifted its holdings in Health Catalyst by 27.3% during the 4th quarter. Wells Fargo & Company MN now owns 39,355 shares of the company's stock worth $278,000 after buying an additional 8,451 shares in the last quarter. Finally, Dynamic Technology Lab Private Ltd acquired a new stake in Health Catalyst in the fourth quarter worth about $232,000. 85.00% of the stock is currently owned by institutional investors.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.